CorrectQuestion: In the development of synthetic biology-based antiviral therapies, what is a primary advantage of using engineered CRISPR-Cas systems?

Wed, 06 May 2026 20:00:13 +0000

**CorrectQuestion: In the development of synthetic biology-based antiviral therapies, what is a primary advantage of using engineered CRISPR-Cas systems?** As breakthrough dialogue continues around next-generation medical innovations, an emerging trend highlights the game-changing potential of synthetic biology in antiviral development—particularly engineered CRISPR-Cas systems. With growing urgency to combat viral diseases more precisely and rapidly, researchers are increasingly focusing on how these advanced gene-editing tools offer a smarter, more adaptable approach compared to earlier antiviral strategies. This question—*What is a primary advantage of using engineered